[Progress in biology and therapy of acute lymphoblastic leukemia].
In the paper recent advances in the etiology and pathogenesis of acute lymphoblastic leukaemia are reviewed. Role of enzymes and cytogenetic abnormalities, oncogenes and gene rearrangements in the biology of this leukaemia is presented. Progress in chemotherapy, immunotherapy and bone marrow transplantation is also discussed.
Robak
T
T
D000328:Adult; D000911:Antibodies, Monoclonal; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000379:methods; D002648:Child; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D000944:Antigens, Differentiation, B-Lymphocyte
Postepy w biologii i terapii ostrej białaczki limfoblastycznej.